Your brain is not fixed. It rewires itself constantly, forming new connections, strengthening useful pathways, pruning unused ones. Neuroscientists call this neuroplasticity, and it is the foundation of learning, memory, and recovery from injury.
The molecules that drive neuroplasticity have specific names: Nerve Growth Factor (NGF) and Brain-Derived Neurotrophic Factor (BDNF). They are proteins that signal neurons to grow, branch, and survive. Without them, the brain loses its ability to adapt.
Researchers have been studying whether compounds in Hericium erinaceus (Lion's Mane mushroom) can stimulate the production of these growth factors. The question is straightforward: can a fungus trigger the molecular machinery of brain repair?
This article examines five PubMed-indexed studies that address that question directly. No hype. No miracle claims. Just the published data, the mechanisms, and the limitations.
What Is Lion's Mane, and Why Are Neuroscientists Studying It?
Lion's Mane (Hericium erinaceus) is a white, shaggy mushroom that grows on hardwood trees across North America, Europe, and Asia. Unlike most medicinal mushrooms studied for immune function, Lion's Mane has attracted attention primarily for its effects on the nervous system.
The reason is chemical. Lion's Mane produces two families of compounds found almost exclusively in the Hericium genus:
Key Bioactive Compounds Under Investigation
- Hericenones (found in the fruiting body): Small molecules that cross the blood-brain barrier and stimulate NGF synthesis in astrocytes
- Erinacines (found in the mycelium): Diterpenoids that stimulate NGF production and have shown neuroprotective effects in preclinical models
- Hericene A: A compound whose pan-neurotrophic mechanism was characterized in 2023, promoting neurite outgrowth through a pathway converging on ERK1/2 signaling
- Beta-D-glucans: Polysaccharides with immunomodulatory properties shared across medicinal mushrooms
The neuroscience research on Lion's Mane focuses on two core mechanisms: stimulating NGF and BDNF production (the growth factors that drive neuroplasticity), and promoting neurite outgrowth (the physical extension of neural connections).
Study 1: The Human Cognitive Trial (Mori 2009)
Double-Blind, Placebo-Controlled Trial of Lion's Mane on Cognitive Function in Older Adults
Japanese men and women aged 50 to 80 with mild cognitive impairment were randomized to receive Lion's Mane tablets (250 mg, 96% dry powder, four tablets three times daily) or placebo for 16 weeks.
The Lion's Mane group showed significantly higher cognitive function scores on the Hasegawa Dementia Scale-Revised (HDS-R) at weeks 8, 12, and 16 compared to placebo. The improvement increased with duration of intake.
However, four weeks after stopping supplementation, scores declined significantly. The cognitive benefit required ongoing intake to maintain.
Small sample size (30 subjects). Effects reversed after discontinuation. The study used whole fruiting body powder, not a standardized extract, making dose-response comparisons with other trials difficult.
Study 2: Hericene A and Pan-Neurotrophic Pathway (Martinez-Marmol 2023)
Hericene A Promotes Neurite Outgrowth and Memory via a Pan-Neurotrophic Pathway Converging on ERK1/2
Researchers at the Queensland Brain Institute, University of Queensland, isolated compounds including N-de phenylethyl isohericerin (NDPIH) and Hericene A from Hericium erinaceus and tested their effects on hippocampal neurons.
Hericene A significantly promoted neurite outgrowth, the physical extension of neuronal projections that form new connections. The mechanism was more complex than a single growth factor pathway. Pharmacological inhibition of the TrkB receptor only partly blocked the neurotrophic activity. Hericene A acts through a pan-neurotrophic pathway converging on ERK1/2 activation, operating partly through BDNF/TrkB and partly through complementary TrkB-independent routes.
Mice fed Lion's Mane extract and Hericene A showed increased neurotrophin expression and significantly enhanced recognition and spatial working memory on novel object recognition and Y-maze tests.
This study was funded by CNG-Bio Inc., a Korean Lion's Mane supplement company.
Study 3: NGF Synthesis and Neurite Outgrowth (Lai 2013)
Aqueous Extract of Lion's Mane Induces NGF Synthesis and Neurite Outgrowth in NG108-15 Neural Cells
This study tested aqueous extract of Hericium erinaceus fruiting body on NG108-15 neuroblastoma-glioma hybrid cells, a standard neural cell line used in neuroscience research.
The extract induced NGF synthesis and significantly promoted neurite outgrowth in NG108-15 cells compared with untreated controls.
NGF is the primary growth factor responsible for the survival and maintenance of cholinergic neurons, the neural population most affected in Alzheimer's disease and age-related cognitive decline. The ability to stimulate NGF production from within the brain (rather than injecting it externally, which cannot cross the blood-brain barrier) is why this finding attracted significant research interest.
NGF cannot be administered as a drug because it does not cross the blood-brain barrier. Compounds that stimulate the brain's own NGF production, and that are small enough to cross the barrier themselves, represent a fundamentally different therapeutic approach. Hericenones are among the very few natural compounds shown to do this.
Study 4: Cognitive Function in Older Adults (Saitsu 2019)
Lion's Mane Supplementation Improves Cognitive Scores vs Placebo in Older Adults
A randomized, double-blind, placebo-controlled parallel-group trial enrolled 31 healthy Japanese adults over 50 years old and administered Hericium erinaceus fruiting body at 2.4 g/day or placebo for 12 weeks.
The Lion's Mane group showed significantly improved MMSE (Mini Mental State Examination) scores versus placebo. Two other cognitive tests (Benton visual retention test and Standard verbal paired-associate learning test) did not show significant differences.
This trial extended the evidence base beyond Mori 2009's mild cognitive impairment population to a general population of healthy older adults, though the benefit was confined to one of three cognitive measures.
Study 5: Peripheral Nerve Regeneration (Wong 2011/2012)
Lion's Mane Aqueous Extract Promotes Peripheral Nerve Regeneration, Comparable to Mecobalamin
Rats with experimentally induced crush injuries to the peroneal nerve were given daily oral doses of Lion's Mane aqueous extract, mecobalamin (a form of vitamin B12 commonly prescribed for nerve repair), or no treatment. The researchers measured the rate and quality of nerve regeneration.
Lion's Mane and mecobalamin produced comparable functional recovery, both outperforming untreated controls. The paper states there was no significant difference in peroneal functional index values among the treated groups. Histologically, however, the mecobalamin group showed more compact axon bundles and more advanced regeneration. Lion's Mane matched mecobalamin on functional recovery. Mecobalamin showed a slight edge on histology. Both clearly outperformed no treatment.
This study extended the neurotrophin research beyond cognition into physical nerve repair, suggesting that Lion's Mane compounds may support peripheral nervous system recovery at a rate comparable to a standard pharmaceutical intervention.
What Does All This Actually Mean?
- Cognitive improvement in two human trials: both Mori 2009 and Saitsu 2019 showed significant improvements vs placebo
- NGF stimulation by Lion's Mane compounds including hericenones, and a pan-neurotrophic pathway via Hericene A: Lion's Mane compounds activate the molecular growth factors and ERK1/2 signaling that drive neuroplasticity
- Nerve regeneration in animal model: peripheral nerve recovery with oral supplementation was comparable to mecobalamin, both better than untreated controls
- Mori 2009 effects reversed after stopping: cognitive benefits required ongoing supplementation
- Most mechanistic data is preclinical or in vitro: the NGF and BDNF findings come from cell cultures and animal models, not human brains
- Both human trials had small samples: 30 subjects (Mori) and 31 subjects (Saitsu)
- "Rebuild your brain" is a question, not a conclusion: no human imaging or structural neuroanatomy study has measured structural brain remodeling from Lion's Mane
- Optimal dosing not established: different studies used different preparations, extracts, and doses
The mechanisms are specific: NGF synthesis via hericenones, a pan-neurotrophic pathway converging on ERK1/2 via Hericene A, neurite outgrowth promotion, peripheral nerve regeneration comparable to mecobalamin. These are identifiable molecular pathways confirmed across multiple independent research groups. This is not vague "brain health" marketing language. These are named compounds acting on named receptors producing measurable structural changes in neurons.
How Alchemy Dose Approaches This
We do not claim our Lion's Mane product treats cognitive decline or repairs nerve damage. We are not a pharmaceutical company and Lion's Mane is not a drug.
What we do:
- Source fruiting body Hericium erinaceus, rich in hericenones (the compounds shown to stimulate NGF)
- Use dual extraction (hot water + alcohol) to capture both polysaccharides and the alcohol-soluble hericenone compounds
- Publish third-party lab test results (Certificates of Analysis) for every batch
- Disclose beta-glucan content so you know what you are actually getting
The Bottom Line
Lion's Mane is not a nootropic miracle drug. No serious researcher claims it is.
But the research is real. Two independent human trials show cognitive improvement. The mechanistic data identifies specific compounds (hericenones, Hericene A) acting on specific pathways (NGF synthesis, a pan-neurotrophic pathway converging on ERK1/2) to produce specific structural changes (neurite outgrowth, nerve regeneration).
No other edible mushroom has this combination of human clinical data and identified neurotrophic mechanisms. That is not marketing. That is what the published literature shows.
The gaps remain significant: small human trials, effects that require continued use, and most mechanistic data from cell cultures and animal models. Larger, longer clinical trials are needed before definitive claims can be made.
We will keep watching the research. We will keep reporting it honestly. And we will never claim more than the evidence supports.
That is the Alchemy Dose standard.
